Efficacy of memantine for elderly patients in the mild stage of Alzheimer's and vascular dementia in UkraineEUROPEAN PSYCHIATRYIF6.72020-03-230PREAI
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multicenter trialINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82014-03-1678OAAI
Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer's Disease and Vascular Dementia: Results from a Randomised Controlled TrialPHARMACOPSYCHIATRYIF2.22011-11-1597OAAI
The Presence and Origin of Autoantibodies Against α4 and α7 Nicotinic Acetylcholine Receptors in the Human Blood: Possible Relevance to Alzheimer's PathologyJOURNAL OF ALZHEIMERS DISEASEIF3.12011-08-0521PRE
Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trialNEUROPSYCHIATRIC DISEASE AND TREATMENTIF2.92011-04-0153OAAI
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trialINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYIF2.82010-12-0793PREAI
Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trialJOURNAL OF THE NEUROLOGICAL SCIENCESIF3.22010-12-0121PREAI